|
2025
|
Invention
|
Binding molecules to tumor associated macrophages and methods of use.
Provided herein are bindin... |
|
|
Invention
|
Method for modulating metabolism.
A method for modulating metabolism is provided which includes ... |
|
|
Invention
|
Compositions and methods for visualizing glycosylation. In some aspects, provided herein are comp... |
|
|
Invention
|
Anti-retroviral therapies and reverse transcriptase inhibitors for treatment of alzheimer's disea... |
|
|
Invention
|
Methods of treating synovial sarcoma pathogenesis by sumo2 inhibition.
Provided herein are metho... |
|
|
Invention
|
Novel application of human airway surfactant, bpifa1, as prophylactic antiviral against respirato... |
|
2024
|
Invention
|
Machine-learning system for diagnosing disorders and diseases and determining drug responsiveness... |
|
|
Invention
|
Recombinant tmem2 extracellular domain and uses thereof.
Described herein is a recombinant TMEM2... |
|
|
Invention
|
Secretin receptor agonists and methods of use. The present application provides compounds of Form... |
|
|
Invention
|
Methods and compositions for the treatment of neurological diseases and disorders. Provided herei... |
|
|
Invention
|
Hells helicase degraders and uses thereof. Disclosed herein are compounds that can degrade lympho... |
|
|
Invention
|
Methods and compositions for cardiac models.
The present disclosure provides for in-vitro genera... |
|
|
Invention
|
Implant and coating to reduce osteolysis.
An implant is provided comprising a substrate having o... |
|
|
Invention
|
Tgr5 antagonists and methods of use. This disclosure provides compounds of Formula (I), and pharm... |
|
|
Invention
|
Positive allosteric modulator of the metabotropic glutamate receptor subtype 2 receptor, synthesi... |
|
|
Invention
|
Uses and methods for promoting increased mitochondrial mass and function.
Disclosed herein are m... |
|
|
Invention
|
Inhibition of glutaryl-coa dehydrogenase for the treatment of melanoma.
Addiction to particular ... |
|
|
Invention
|
Metabotropic glutamate receptor positive allosteric modulators and uses thereof. Provided herein ... |
|
|
Invention
|
Metabotropic glutamate subtype-2 and -3 receptor positive allosteric modulators and uses thereof.... |
|
|
Invention
|
Pikfyve inhibitors.
The present application provides, inter alia, a compound of Formula (I):
T... |
|
|
Invention
|
Molecular glues targeting a transcriptional regulator of aberrant metabolic states. Composition a... |
|
|
Invention
|
Epha4 antagonists and uses thereof. Described herein are EphA4 receptor antagonists, pharmaceutic... |
|
|
Invention
|
Tumor associated monocyte/macrophage binding peptide and methods of use thereof.
Disclosed are c... |
|
|
Invention
|
Runx1 modulators. Provided herein are compounds, compositions, and methods for lowering expressio... |
|
|
Invention
|
Methods and compositions for cancer treatment by targeting axl signaling.
Methods of treating ca... |
|
|
Invention
|
Btla fusion protein agonists and uses thereof.
The present invention is based on the seminal dis... |
|
|
Invention
|
Sgf29 as a target for hox/myc driven cancers.
Described herein are methods and compositions for ... |
|
|
Invention
|
Psgl1 antagonists and uses thereof. Described and provided herein are compositions and methods us... |
|
|
Invention
|
Fused ring compound having urea structure. The present invention relates to a novel fused ring co... |
|
|
Invention
|
Methods and compositions for treating perinatal hypoxic-ischemic brain injury. e.ge.g., HFB 2050 ... |
|
|
Invention
|
Tyramine containing hydroxycinnamic acid amide derivatives and methods of use thereof.
Tyramine ... |
|
|
Invention
|
Uses of hnf4 alpha agonists.
Provided herein are methods for using HNF4α agonists and pharmaceut... |
|
|
Invention
|
Non-polyamine based polyamine transport inhibitors and their use in the treatment of human cancer... |
|
2023
|
Invention
|
Inhibitors of cancer invasion, attachment, and/or metastasis.
Provided herein are, inter alia, c... |
|
|
Invention
|
Universal targeting strategy to inhibit replication of zikv and flaviviruses.
Methods and compos... |
|
|
Invention
|
Role of pvt1 in the diagnosis and treatment of myc-driven cancer.
Disclosed herein are methods o... |
|
|
Invention
|
Cardiogenic mesoderm formation regulators.
This disclosure relates to cardiogenic mesoderm forma... |
|
|
Invention
|
Compositions that target tumor-associated macrophages and methods of use therefor. Described here... |
|
2022
|
Invention
|
Metabotropic glutamate receptor positive allosteric modulators (pams) and uses thereof.
Provided... |
|
|
Invention
|
Inhibitors of the oncogenic shp2 phosphatase and uses thereof.
Described herein are compounds wh... |
|
|
Invention
|
Inhibitor of apoptosis (iap) protein antagonists.
Provided herein are compounds that modulate th... |
|
|
Invention
|
Targeted delivery system and methods of use therefor. Disclosed are peptides and peptidomimetics ... |
|
|
Invention
|
Inhibitors of serine/threonine protein kinase stk3 or stk4 and uses thereof.
Described herein ar... |
|
|
Invention
|
Methods for treating a subtype of colorectal cancer.
This invention relates generally to methods... |
|
|
Invention
|
Compositions and methods for inhibiting human blood protein vitronectin.
A method for inhibiting... |
|
|
Invention
|
Methods and compositions for treating chronic liver disease and hepatocellular carcinoma.
Descri... |
|
|
Invention
|
Methods and compositions for cell reprogramming.
This present disclosure provides methods and ph... |
|
|
Invention
|
Methods and compositions for treating hypophosphatasia.
Described herein are compositions and me... |
|
|
Invention
|
Compounds for protection of noise-induced hearing-loss.
The present disclosure provides composit... |
|
|
Invention
|
Sars-cov-2 therapeutics.
Disclosed herein include methods, compositions, and kits suitable for u... |
|
2016
|
G/S
|
Charitable fundraising services for promoting research,
education and other activities related t... |
